col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


45 Results       Page 1

 [1] 
Elsevier: The Lancet HIV
  original article Date Title Authors   All Authors
1 [GO] 2022―May―10 A collision of pandemics: HIV and COVID-19 Charles Feldman, Jarrod Zamparini
2 [GO] 2022―May―10 Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19 Silvia Bertagnolio, Soe Soe Thwin, Ronaldo Silva, Sairaman Nagarajan, Waasila Jassat, Robert Fowler, et al. (+5)
3 [GO] 2022―Apr―27 HIV and COVID-19: juxtaposition of two pandemics John Nkengasong
4 [GO] 2022―Apr―27 Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial Shabir A Madhi, Dhayendre Moodley, Sherika Hanley, Moherndran Archary, Zaheer Hoosain, Umesh Lalloo, et al. (+41)
5 [GO] 2022―Mar―22 Can COVID-19 changes reduce stigma in African HIV clinics? Sarah M Lofgren, Joanita Kigozi, Nakita G Natala, Sharon Tsui, Anita Arinda, Vanessa Akinyange, et al. (+3)
6 [GO] 2021―Dec―08 COVID-19 antivirals must not affect HIV drug supply Melissa Barber, Ameet Sarpatwari, Christa Cepuch
7 [GO] 2021―Nov―01 Prioritise people with HIV for COVID-19 vaccination The Lancet HIV
8 [GO] 2021―Oct―15 Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study Daniel K Nomah, Juliana Reyes-Urueña, Yesika Díaz, Sergio Moreno, Jordi Aceiton, Andreu Bruguera, et al. (+95)
9 [GO] 2021―Oct―15 Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data Xueying Yang, Jing Sun, Rena C Patel, Jiajia Zhang, Siyuan Guo, Qulu Zheng, et al. (+19)
10 [GO] 2021―Oct―14 More evidence for worse COVID-19 outcomes in people with HIV Marta Boffito, Laura Waters
11 [GO] 2021―Aug―17 Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial Shabir A Madhi, Anthonet L Koen, Alane Izu, Lee Fairlie, Clare L Cutland, Vicky Baillie, et al. (+32)
12 [GO] 2021―Aug―04 Epidemiology of severe COVID-19 from South Africa Shabir A Madhi, Jeremy Nel
13 [GO] 2021―Aug―04 Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study Waasila Jassat, Cheryl Cohen, Stefano Tempia, Maureen Masha, Susan Goldstein, Tendesayi Kufa, et al. (+1567)
14 [GO] 2021―Aug―03 Young people with HIV struggle during another pandemic Christabel Ligami
15 [GO] 2021―Jun―18 Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial John Frater, Katie J Ewer, Ane Ogbe, Mathew Pace, Sandra Adele, Emily Adland, et al. (+63)
16 [GO] 2021―Jun―18 SARS-CoV-2 vaccination in people with HIV Matthew A Spinelli
17 [GO] 2021―Jun―03 COVID-19 shows need for UN General Assembly push to end AIDS Shannon Hader
18 [GO] 2021―Jun―01 Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV Emma Touizer, Aljawharah Alrubayyi, Chloe Rees-Spear, Natasha Fisher-Pearson, Sarah A Griffith, Luke Muir, et al. (+9)
19 [GO] 2021―Apr―30 SARS-CoV-2 immunity and HIV infection: total recall? Nicolas Dauby, Charlotte Martin
20 [GO] 2021―Apr―30 SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study Matthew A Spinelli, Kara L Lynch, Cassandra Yun, David V Glidden, Michael J Peluso, Timothy J Henrich, et al. (+2)
21 [GO] 2021―Apr―27 Overview of SARS-CoV-2 infection in adults living with HIV Juan Ambrosioni, José Luis Blanco, Juliana M Reyes-Urueña, Mary-Ann Davies, Omar Sued, Maria Angeles Marcos, et al. (+44)
22 [GO] 2021―Feb―21 The potential effect of COVID-19-related disruptions on HIV incidence and HIV-related mortality among men who have sex with men in the USA: a modelling study Kate M Mitchell, Dobromir Dimitrov, Romain Silhol, Lily Geidelberg, Mia Moore, Albert Liu, et al. (+4)
23 [GO] 2021―Feb―06 The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis Jienchi Dorward, Thokozani Khubone, Kelly Gate, Hope Ngobese, Yukteshwar Sookrajh, Siyabonga Mkhize, et al. (+7)
24 [GO] 2021―Feb―03 Brazil sustains HIV response during the COVID-19 pandemic Gerson F Mendes Pereira
25 [GO] 2021―Jan―23 Do not repeat mistakes from HIV in COVID-19 response The Lancet HIV
26 [GO] 2020―Dec―30 Maintaining ART services during COVID-19 border closures: lessons learned in Namibia Linea Hans, Steven Y Hong, Laimi S N Ashipala, Leonard Bikinesi, Ndapewa Hamunime, Jacques W N Kamangu, et al. (+2)
27 [GO] 2020―Dec―13 COVID-19 death in people with HIV: interpret cautiously Laura J Waters, Anton L Pozniak
28 [GO] 2020―Dec―13 HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform Krishnan Bhaskaran, Christopher T Rentsch, Brian MacKenna, Anna Schultze, Amir Mehrkar, Chris J Bates, et al. (+19)
29 [GO] 2020―Dec―01 COVID-19 threatens HIV care continuity in Brazil Joe Parkin Daniels
30 [GO] 2020―Oct―08 Pandemics have psychosocial and sociocultural burdens Lisa McDaid, Paul Flowers
31 [GO] 2020―Aug―06 Modelling the impact of COVID-19 on HIV Maia Lesosky, Landon Myer
32 [GO] 2020―Aug―06 Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models Britta L Jewell, Edinah Mudimu, John Stover, Debra ten Brink, Andrew N Phillips, Jennifer A Smith, et al. (+13)
33 [GO] 2020―Aug―04 Control of epidemics by jails: lessons for COVID-19 from HIV Tochi Ohuabunwa, Anne C Spaulding
34 [GO] 2020―Aug―03 PrEP retention and prescriptions for pregnant women during COVID-19 lockdown in South Africa Dvora L Joseph Davey, Linda-Gail Bekker, Nyiko Mashele, Pamina Gorbach, Thomas J Coates, Landon Myer
35 [GO] 2020―Jul―17 Postexposure prophylaxis during COVID-19 lockdown in Melbourne, Australia Eric P F Chow, Jane S Hocking, Jason J Ong, Tiffany R Phillips, Christopher K Fairley
36 [GO] 2020―May―28 Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort Pilar Vizcarra, María J Pérez-Elías, Carmen Quereda, Ana Moreno, María J Vivancos, Fernando Dronda, et al. (+31)
37 [GO] 2020―May―28 COVID-19 in people with HIV Zhe Xu, Chao Zhang, Fu-Sheng Wang
38 [GO] 2020―May―25 HIV postexposure prophylaxis during COVID-19 Muhammad Junejo, Nicolo Girometti, Alan McOwan, Gary Whitlock, Keerti Gedela, Nicolo Girometti, et al. (+7)
39 [GO] 2020―May―15 COVID-19 in patients with HIV Rachael Jones, Mark Nelson, Margherita Bracchi, David Asboe, Marta Boffito
40 [GO] 2020―May―15 COVID-19 in patients with HIV - Authors' reply José M Miró, Juan Ambrosioni, Jose L Blanco
41 [GO] 2020―Apr―24 When pandemics collide The Lancet HIV
42 [GO] 2020―Apr―15 COVID-19 in patients with HIV: clinical case series Jose L Blanco, Juan Ambrosioni, Felipe Garcia, Esteban Martínez, Alex Soriano, Josep Mallolas, Jose M Miro
43 [GO] 2020―Apr―13 Three lessons for the COVID-19 response from pandemic HIV James Hargreaves, Calum Davey, James Hargreaves, Calum Davey, Judith Auerbach, Jamie Blanchard, et al. (+24)
44 [GO] 2020―Apr―08 Tuberculosis and HIV responses threatened by COVID-19 Paul Adepoju
45 [GO] 2020―Apr―06 Maintaining HIV care during the COVID-19 pandemic Hongbo Jiang, Yi Zhou, Weiming Tang
 [1] 

45 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.011 sec